ArticleInvestigational new drugs2019

Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.

Glen J Weiss et al.PubMed ↗Publisher ↗

No numbers read from the abstract.